L-carnitine and contribution to normal lipid metabolism : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/298818

Lähdeviite

EFSA Panel Dietetic Prod Nut 2018 , ' L-carnitine and contribution to normal lipid metabolism : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 ' , EFSA Journal , vol. 16 , no. 1 , 5137 . https://doi.org/10.2903/j.efsa.2018.5137

Julkaisun nimi: L-carnitine and contribution to normal lipid metabolism : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Tekijä: EFSA Panel Dietetic Prod Nut
Tekijän organisaatio: Department of Food and Nutrition
Food Quality & Safety
Food Sciences
Päiväys: 2018-01
Kieli: eng
Sivumäärä: 9
Kuuluu julkaisusarjaan: EFSA Journal
ISSN: 1831-4732
DOI-tunniste: https://doi.org/10.2903/j.efsa.2018.5137
URI: http://hdl.handle.net/10138/298818
Tiivistelmä: Following an application from Lonza Ltd., submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No1924/2006 via the Competent Authority of Germany, the EFSA Panelon Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to L-carnitine and normal lipid metabolism. The food that is proposed as the subject of the health claim is L-carnitine. The Panelconsiders that L-carnitine is sufficiently characterised. The claimed effect proposed by the applicant is normal lipid metabolism'. The target population proposed by the applicant is the general population. The Panelconsiders that contribution to normal lipid metabolism is a beneficial physiological effect. The applicant proposes that the claim submitted with this application is based on the essentiality of a nutrient. The Panelconsiders that the evidence provided does not establish that dietary L-carnitine is required to maintain normal lipid metabolism in the target population, for which the claim is intended. The Panelconcludes that a cause and effect relationship has not been established between the consumption of L-carnitine and contribution to normal lipid metabolism in the target population. (c) 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Avainsanat: L-carnitine
lipid metabolism
health claim
PARENTERAL-NUTRITION
REQUIREMENTS
OXIDATION
GUIDANCE
CYCLE
416 Food Science
Vertaisarvioitu: Kyllä
Tekijänoikeustiedot: cc_by_nd
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: publishedVersion


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
Panel_et_al_2018_EFSA_Journal_4.pdf 565.9KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot